In this edition, dermatologists 'uniquely positioned' to aid human trafficking victims; FDA approves Cosentyx for hidradenitis suppurativa and more. Read the full coverage here: Dermatologists 'uniquely positioned' to recognize, aid human trafficking victims FDA approves Cosentyx as first IL-17A inhibitor for hidradenitis suppurativa FDA approves Stelara biosimilar for treatment of psoriasis, multiple inflammatory diseases RECELL system efficacious in vitiligo repigmentation Isotretinoin efficacious in seborrheic dermatitis treatment References: Elbuluk N. Optimizing melanocyte cell transplant procedure for treatment of vitiligo. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago. Kourosh S. The role of dermatologic surgeons in advocating for those affected by human trafficking. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago. Press Release Press Release Tan MG, et al. Isotretinoin for the management of moderate to severe seborrheic dermatitis. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago.

Ver todos los episodios